Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

PubWeight™: 2.97‹?› | Rank: Top 1%

🔗 View Article (PMID 11984526)

Published in Gastroenterology on May 01, 2002

Authors

Kenichi Ikejima1, Yoshiyuki Takei, Hajime Honda, Miyoko Hirose, Mutsuko Yoshikawa, Yan-Jun Zhang, Tie Lang, Toru Fukuda, Shunhei Yamashina, Tsuneo Kitamura, Nobuhiro Sato

Author Affiliations

1: Department of Gastroenterology, Central Laboratory for Medical Science, Juntendo University School of Medicine, Tokyo, Japan.

Articles citing this

Liver fibrosis. J Clin Invest (2005) 17.27

Mechanisms of hepatic fibrogenesis. Gastroenterology (2008) 11.98

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28

Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut (2005) 5.39

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer (2009) 2.19

Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol (2011) 1.85

Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci (2011) 1.70

Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J (2004) 1.61

Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2007) 1.61

The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol (2005) 1.49

Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology (2009) 1.48

Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut (2004) 1.42

Spaceflight Activates Lipotoxic Pathways in Mouse Liver. PLoS One (2016) 1.38

Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ. Am J Respir Crit Care Med (2011) 1.34

Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem (2010) 1.33

Liver diseases and metabolic syndrome. J Gastroenterol (2008) 1.33

Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol (2011) 1.32

Cytokines and the pathogenesis of non-alcoholic steatohepatitis. Gut (2005) 1.30

Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm (2009) 1.26

Adipocytokines and liver disease. J Gastroenterol (2008) 1.25

Apoptosis and cytokines in non-alcoholic steatohepatitis. Clin Liver Dis (2009) 1.21

Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol (2012) 1.21

Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem (2003) 1.19

Mononuclear cells in liver fibrosis. Semin Immunopathol (2009) 1.15

Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. Am J Pathol (2008) 1.11

The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Inflammation (2007) 1.10

Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Mol Endocrinol (2006) 1.09

Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis (2009) 1.08

Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3). J Cell Biochem (2010) 1.07

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2014) 1.07

Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology (2009) 1.04

Cytokines and STATs in Liver Fibrosis. Front Physiol (2012) 1.02

Leptin and liver fibrosis: a matter of fat. Gastroenterology (2002) 1.01

Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosis. Biochem J (2011) 0.99

Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? World J Gastroenterol (2014) 0.99

HCC, diet and metabolic factors: Diet and HCC. Hepat Mon (2011) 0.97

Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis. Mol Med (2011) 0.95

Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. Lipids Health Dis (2010) 0.95

In vitro and in vivo protection of stellate cells from apoptosis by leptin. Dig Dis Sci (2006) 0.94

Leptin in hepatocellular carcinoma. World J Gastroenterol (2010) 0.93

Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch (2003) 0.93

Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools. Front Immunol (2014) 0.92

Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotide. Dig Dis Sci (2005) 0.91

Leptin administration exacerbates thioacetamide-induced liver fibrosis in mice. World J Gastroenterol (2005) 0.90

Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Semin Immunopathol (2012) 0.90

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. J Clin Exp Hepatol (2015) 0.89

Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol (2015) 0.89

Studies on oxidative stress in liver diseases: important future trends in liver research. Med Mol Morphol (2006) 0.89

Bioconjugation of oligonucleotides for treating liver fibrosis. Oligonucleotides (2007) 0.88

Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans. PLoS One (2013) 0.87

CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Semin Immunopathol (2013) 0.87

CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis. Toxicol Appl Pharmacol (2013) 0.86

Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? Mol Cancer Res (2014) 0.86

High serum leptin is an independent risk factor for non-response patients with low viremia to antiviral treatment in chronic hepatitis C. World J Gastroenterol (2006) 0.85

Repeated whiskey binges promote liver injury in rats fed a choline-deficient diet. J Hepatol (2006) 0.84

Renal effects of the novel selective adenosine A1 receptor blocker SLV329 in experimental liver cirrhosis in rats. PLoS One (2011) 0.84

Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. Dig Dis Sci (2007) 0.84

Involvement of DNA damage response pathways in hepatocellular carcinoma. Biomed Res Int (2014) 0.84

Expression of leptin receptors in hepatic sinusoidal cells. Comp Hepatol (2004) 0.84

Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C. Can J Gastroenterol (2007) 0.84

Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis (2011) 0.84

Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis. World J Gastroenterol (2015) 0.83

Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors. J Lipid Res (2013) 0.83

Risk factors and mechanisms of non-alcoholic steatohepatitis. Pathophysiology (2008) 0.83

The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast. PLoS One (2011) 0.83

Leptin and cancer: Pathogenesis and modulation. Indian J Endocrinol Metab (2012) 0.83

The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology. Curr Neuropharmacol (2008) 0.82

A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells. Histochem Cell Biol (2007) 0.82

Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease. Obesity (Silver Spring) (2010) 0.82

Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis. Biochim Biophys Acta (2015) 0.82

HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis. Sci Rep (2013) 0.81

Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. Am J Physiol Endocrinol Metab (2014) 0.80

Resistin mediates the hepatic stellate cell phenotype. World J Gastroenterol (2013) 0.80

Leptin in the field of hepatic fibrosis: a pivotal or an incidental player? Dig Dis Sci (2006) 0.80

Involvement of leptin in the progression of experimentally induced peritoneal fibrosis in mice. Acta Histochem Cytochem (2013) 0.80

Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression? J Gastroenterol (2009) 0.80

Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver. Curr Pathobiol Rep (2015) 0.79

Energy metabolism and the skeleton: Reciprocal interplay. World J Orthop (2012) 0.79

Long-term Branched Chain Amino Acid Supplementation Ameliorates Diethylnitrosamine-induced Liver Glutathione S-transferase-p Positivity in Zucker Fatty Rats. J Clin Exp Hepatol (2013) 0.77

Liver inflammation and fibrosis. J Clin Invest (2017) 0.77

Leptin induces an inflammatory phenotype in lean Wistar rats. Mediators Inflamm (2010) 0.77

NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes. PLoS One (2015) 0.76

Panhypopituitarism due to Absence of the Pituitary Stalk: A Rare Aetiology of Liver Cirrhosis. Case Rep Endocrinol (2016) 0.75

Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity. PLoS One (2016) 0.75

Therapeutic effect of hybrid training of voluntary and electrical muscle contractions in middle-aged obese women with nonalcoholic fatty liver disease: a pilot trial. Ther Clin Risk Manag (2015) 0.75

Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. Obes Surg (2017) 0.75

Plumbagin Alleviates Capillarization of Hepatic Sinusoids In Vitro by Downregulating ET-1, VEGF, LN, and Type IV Collagen. Biomed Res Int (2017) 0.75

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ (2010) 3.57

Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med (2005) 2.59

Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology (2002) 2.34

A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis (2013) 2.30

miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun (2008) 2.16

Vitamin E decreases bone mass by stimulating osteoclast fusion. Nat Med (2012) 2.04

Rare diseases and legislation in China. Lancet (2010) 1.96

H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol (2002) 1.88

Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol (2008) 1.85

Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci U S A (2003) 1.72

Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial. Am J Gastroenterol (2010) 1.61

Loss of autophagy promotes murine acetaminophen hepatotoxicity. J Gastroenterol (2011) 1.61

Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemother (2005) 1.59

Phytobezoars. Intern Med (2008) 1.57

Occult regurgitation of pancreatic juice into the biliary tract: diagnosis with secretin injection magnetic resonance cholangiopancreatography. Gastrointest Endosc (2002) 1.55

Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients. Respir Med (2010) 1.54

Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol (2002) 1.53

Brain masculinization requires androgen receptor function. Proc Natl Acad Sci U S A (2004) 1.51

Improvement of gastric atrophy after Helicobacter pylori eradication therapy. J Clin Gastroenterol (2003) 1.50

miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett (2009) 1.46

Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem (2006) 1.45

Anemia caused by a gastric inflammatory fibroid polyp. Gastrointest Endosc (2007) 1.42

Genetic distance of SARS coronavirus from the recent natural case. Vet Microbiol (2006) 1.40

SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. J Biol Chem (2005) 1.36

Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. Am J Pathol (2002) 1.30

Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan. Helicobacter (2009) 1.29

Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol (2005) 1.24

Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci U S A (2008) 1.24

Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-gamma, pioglitazone. J Pharmacol Exp Ther (2003) 1.24

The role of leptin in progression of non-alcoholic fatty liver disease. Hepatol Res (2005) 1.23

China's first rare-disease registry is under development. Lancet (2011) 1.23

Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun (2002) 1.21

Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production. Gastroenterology (2002) 1.20

Dietary glycine prevents chemical-induced experimental colitis in the rat. Gastroenterology (2003) 1.18

Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. J Med Microbiol (2009) 1.11

Ease of early gastric cancer demarcation recognition: a comparison of four magnifying endoscopy methods. J Gastroenterol Hepatol (2009) 1.11

Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genet (2010) 1.09

Health technology assessment in China. Health Aff (Millwood) (2013) 1.09

Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Biochem Biophys Res Commun (2007) 1.08

Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy. J Gastroenterol (2009) 1.08

Retracted Distinct function of 2 chromatin remodeling complexes that share a common subunit, Williams syndrome transcription factor (WSTF). Proc Natl Acad Sci U S A (2009) 1.06

Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers. Oncogene (2004) 1.04

Purification and identification of a BMP-like factor from bovine serum. Biochem Biophys Res Commun (2006) 1.04

Carminerin contributes to chondrocyte calcification during endochondral ossification. Nat Med (2006) 1.03

Coexistence of esophageal superficial carcinoma and multiple leiomyomas: A case report. World J Gastroenterol (2006) 1.01

Role of adipocytokines in hepatic fibrogenesis. J Gastroenterol Hepatol (2007) 1.01

Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol (2002) 1.01

Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat. J Hepatol (2006) 1.00

Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up. Scand J Gastroenterol (2005) 0.99

Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors. Oncogene (2004) 0.99

Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J Biol Chem (2010) 0.98

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatol Res (2015) 0.98

Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. Int J Oncol (2008) 0.97

Molecular tracing of Japan-indigenous hepatitis E viruses. J Gen Virol (2006) 0.97

A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res Clin Pract (2009) 0.97

Sivelestat sodium hydrate improves septic acute lung injury by reducing alveolar dysfunction. Res Commun Mol Pathol Pharmacol (2006) 0.96

Increased esophageal sensitivity to acid and saline in patients with nonerosive gastro-esophageal reflux disease. J Clin Gastroenterol (2006) 0.96

Occult pancreatobiliary reflux in patients with a normal pancreaticobiliary junction. Gastrointest Endosc (2003) 0.96

Recessive inheritance of population-specific intronic LINE-1 insertion causes a rotor syndrome phenotype. Hum Mutat (2015) 0.95

DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Med Oncol (2011) 0.94

Local elasticity imaging of vascular tissues using a tactile mapping system. J Artif Organs (2009) 0.94

Significance of measuring S100A12 and sRAGE in the serum of sepsis patients with postoperative acute lung injury. Dig Surg (2010) 0.94

SRC-1 is necessary for skeletal responses to sex hormones in both males and females. J Bone Miner Res (2004) 0.94

Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology (2013) 0.94

Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells. J Hepatol (2010) 0.94

Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J Gastroenterol (2005) 0.94

Interleukin-11 links oxidative stress and compensatory proliferation. Sci Signal (2012) 0.93

Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs. Biochem Biophys Res Commun (2007) 0.93

Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. J Bone Miner Res (2010) 0.93